Skip to main content
. 2016 Sep 6;21(1):154–164. doi: 10.1111/jcmm.12953

Figure 2.

Figure 2

MXRA5 is present in CKD patients. (A) Urine supernatant. (B) Urine sediment. Western blot shows bands recognized by anti‐MXRA5 antibody in urine of CKD patients but not in healthy controls (N = 2 healthy controls and 3 CKD patients). (C) MXRA5 mRNA expression in ADPKD cysts or normal kidneys assessed by RT‐qPCR (N = 3 controls and 6 ADPKD patients, *P < 0.001 versus control). (D) MXRA5 immunohistochemistry in ADPKD cysts or normal kidneys (N = 6 controls and 6 ADPKD patients). Representative image. (E) MXRA5 immunohistochemistry in renal fibrosis and control kidney (N = 2 controls and 1 fibrotic, non‐ADPKD kidney).